Hearken to this text |
Epica Worldwide raised an $18 million development capital credit score facility with varied Avenue Capital Group funds. The preliminary funding of $13.5 million will probably be used to refinance present debt, assist strategic enlargement, and speed up analysis and improvement initiatives. A further $4.5 million is on the market upon the achievement of particular efficiency milestones.
The Landrum, S.C.-based firm develops superior medical imaging and precision robotics expertise. It holds 75 issued and pending patents on its medical imaging and robotics platforms within the U.S., EU, and different nations. Its robots work in healthcare, veterinary care, orthotics and prosthetics, aerospace, automotive, manufacturing, and extra.
“This financing marks a big milestone for Epica,” mentioned Joe Soto, CEO of Epica Worldwide. “The capital infusion from Avenue Capital will empower us to strengthen our monetary basis, increase our market presence, and speed up the event of groundbreaking applied sciences that may form the way forward for medical imaging and robotics. We’re thrilled to associate with Avenue Capital, a agency with a confirmed observe file of supporting progressive firms.”
Avenue Enterprise Alternatives Fund, L.P. and Avenue Enterprise Alternatives Fund II, L.P., that are funds of Avenue Capital Group, participated within the funding spherical. The expansion capital mortgage has a four-year time period and consists of provisions for Avenue Capital to obtain a 0.5% fairness stake in Epica Worldwide. It consists of an possibility to speculate an extra $2 million in fairness inside two years. The lender additionally has the best to transform as much as $3.5 million of their principal into frequent inventory at a worth of $8.50 per share.
Epica focuses on robots for manufacturing processes. For instance, the SandRob system can sand, polish and trim complicated shapes of any scale or measurement. It options an lively power suggestions system that controls the power exerted on the handled floor, to realize totally different outcomes on the identical work piece.
The corporate additionally develops ScultoRob, a 7-axis robotic for milling and turning operations on fashions and prototypes comprised of marble, stone, wooden, styrofoam and different supplies. ScultoRob can be utilized as a versatile milling heart.
This strategic financing aligns with a broader trade pattern towards elevated funding in medical expertise, Epica mentioned. That is very true in areas similar to minimally invasive surgical procedure, image-guided remedy, and synthetic intelligence-powered diagnostics.
“We’re excited to associate with Epica Worldwide and assist their mission to revolutionize medical imaging and robotics,” mentioned Chad Norman, senior portfolio supervisor at Avenue Capital. “Epica’s proprietary expertise platforms and mental property portfolio place them for continued success in a quickly rising market. We look ahead to an extended and fruitful partnership.”